While its still new, scientists are excited about its potential, as it has shown significant results in treating obesity
The aggressive titration tail in the 12 mg arm of the Phase 2 trial was strongly associated with higher rates of transient gastrointestinal adverse events, which is why researchers generally favor slower escalation when tolerability is prioritized
CrossRef Natural Product Treatment for Metabolic Dysfunction-Associated Steatotic Liver Disease: Targeted Mitochondrial Quality Control Jing Liu, Fuxing Li, Qianru Zeng, Wenxiao Hu, Le Yang, Shengping Luo, Fang Lv, Dingxiang Li, Yihui Deng Drug Design, Development and Therapy .2026
Frequently Asked Questions What is Retatrutide used for in research
Glucagon-Like Peptide-1: Glucose Homeostasis and Beyond
GLP-1 agonist benefits to consider For those who are at greater risk of cardiovascular issues, some of the GLP-1 receptor agonists have shown cardiovascular benefits or a neutral cardiovascular profile
